View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
The British Veterinary Dental Association has officially launched its own new section on VetSurgeon.org to help its members share ideas and experiences amongst each other.
The new BVDA section on VetSurgeon contains a dedicated forum for discussing veterinary dentistry. There's also a photo and video sharing gallery in which to share and discuss interesting cases. Members can also catch up on association news and hold private 'conversations' between each other using VetSurgeon's sophisticated peer-to-peer networking system.
All veterinary surgeons can visit and read content in the BVDA section on VetSurgeon. However, only BVDA members can join and participate.
A downloadable application form for BVDA membership is available from the 'About us' section.
Lisa Milella MRCVS, BVDA President said: "We're very excited about the potential that VetSurgeon offers us to share information about veterinary dentistry both amongst ourselves and with the wider profession"
Arlo Guthrie, editor and publisher of VetSurgeon said: "I'm really pleased to welcome the BVDA to VetSurgeon. They now sit alongside the Small Animal Medicine Society on the site, and I hope will be joined by more veterinary associations in the future, so that they are all conveniently in once place for easy availability to all practitioners."
Click here to visit the new BVDA section on VetSurgeon.
Intervet/Schering-Plough Animal Health has announced that Metricure is now back in stock and available from the veterinary wholesalers with immediate effect.
Metricure is the only licensed intra-uterine antibiotic for the treatment of endometritis and is specially designed for the anaerobic intra-uterine environment.
The company would like to thank the profession for its patience and understanding, and looks forward to supporting vets striving to improve fertility on clients' farms.
Please contact the Intervet/Schering-Plough Veterinary Support Group on 01908 685685 if you require any further information.
The RCVS Charitable Trust is seeking two creative and energetic UK-based veterinary students to attend the British Science Festival in Aberdeen from 4-9 September 2012.
The Trust says that the students will be required to use their observations and experiences to help it develop future outreach activities to inform and inspire public audiences about aspects of veterinary clinical practice and research, and will have all their expenses paid by the Trust.
Entrants need to write to the RCVS Charitable Trust to say how they would go about meeting this challenge, ideally giving examples that demonstrate their proven innovative abilities. The deadline for entries is 9 July, after which the entries will be considered by a competition panel who will decide the winners. Entrants must be able to commit to attending the entire festival and to deliver a feedback presentation to the competition panel on 31 October. Entrants should also be willing and able to compile a video diary or blog to feedback their experiences.
Further information and details about how to enter are available at http://trust.rcvs.org.uk/home/. The successful applicants will be announced at the end of July.
Defra has announced the detection of Bluetongue (Serotype 1) (BTV1) in five imported cattle on a premises near Blackpool in Lancashire.
The animals originated from within the BTV1 and 8 Restricted Zone in the south west of France and were detected as a result of post-import testing carried out by Defra on all Bluetongue susceptible animals arriving from continental Europe. The animals' documentation complied with the EU Bluetongue rules governing the movement of livestock as the movement occurred at least 60 days after they had been vaccinated.
This is the first case of BTV1 infection in the UK and the five animals have been culled as they may pose a disease threat to other animals. One further animal from the same consignment has also been culled. Test results for that animal were positive for bluetongue although it was not possible to determine the serotype.
There is no evidence that BTV1 is circulating in the UK and no additional control zones have been declared.
This response is in accordance with Defra's Bluetongue Control Strategy. The premises are now under restriction while an epidemiological investigation takes place. This will include further checks on the other animals present on the premises.
Chief Veterinary Officer Nigel Gibbens said: "This is the first case of BTV1 infected animals being imported into the UK. Taking into account the epidemiological evidence and the consideration of the risk represented to British livestock, I have taken the decision to cull these animals.
"This incident shows how important it is for farmers to consider potential disease risks when buying stock. Buyers need to consider how best to protect their own businesses and those of their neighbours and make sure they are clear about the stock they are intending to buy."
Defra continues to test all susceptible animals imported to the UK from continental Europe for all strains of Bluetongue and continues to urge industry to consider the risks and check the health and vaccination status of animals when sourcing any animals from within the UK or abroad.
In line with EU legislation, and our UK Control Strategy agreed with industry, control measures are in place in UK and abroad to prevent the spread of Bluetongue from existing zones around Europe:
Janssen Animal Health has launched a new website providing information on the subject of coccidiosis in calves and lambs: www.takingcareofcoccidiosis.com.
The website builds on the findings of an expert workshop on bovine coccidiosis held at the First European Buiatrics Conference, which was facilitated by Janssen. In particular, the site looks at all of the areas that the experts focused on as being especially problematic, including immunity, sources of infection, risk factors, prevention and treatment.
According to the company, arriving at a diagnosis of coccidiosis is not always straightforward: it must be supported by history and clinical signs, as well as evidence of pathogenic species of the Eimeria parasite. Interpretation of oocyte counts can be particularly difficult and results have to be viewed in the context of the farm situation. The site contains explanations about the timing of sampling and how that can impact upon the results.
Janssen adds that treatment has traditionally relied on fluid therapy and the use of sulphonamide drugs but recommendations on the use of more recently introduced treatments such as diclazuril (Vecoxan) focus on single dose treatments administered 14 days after a stress factor - such as moving to a higher risk environment, weaning or transportation. The various treatment strategies including prophylactic and metaphylactic approaches are described for those who have experienced problems with coccidiosis in the past and want to avoid recurrence on an individual farm.
Janssen says the site is an ideal on-line resource for veterinary professionals, SQPs and farmers looking to update their knowledge, seeking a tool that explains the disease in greater depth or just searching for specific information that helps in their own individual situation or with interpretation of a difficult case, www.takingcareofcoccidiosis.com/.
Braving the elements, a record 12 candidates sat the examinations for the Certificate in Veterinary Practice Management last week, seven of which passed their selected elements, and four of which have been awarded their certificate.
The new CVPMs are, Julie Beacham at Wendover Heights Veterinary Centre in Aylesbury, Liz Howes at The Oxford Cat Clinic in Oxford, Helen Kington from Hungerford and Renay Rickard at the Pelyn Veterinary Group in Lostwithiel. An official presentation of the awards will take place at the Veterinary Practice Management Association Congress Dinner on 28th January 2010 at the Chesford Grange Hotel, Kenilworth, Warwickshire.
The candidates are managers in very different types of veterinary businesses, which the VPMA says is confirmation that the CVPM is applicable and has wide appeal in veterinary management.
Lucy Bartlett of CVS (UK) Ltd, Straight Mile Equine Clinic, Lisa Marter of The Arundel Equine Hospital and Steven Broomfield of The Blue Cross, were also successful in achieving a pass in the written and oral sections of the examination and will be able to complete the CVPM by submitting and passing the portfolio section of the exam next year.
There are now 61 holders of the CVPM since its inception in 1996. The next examination session will be held on 2nd December 2011.
Dechra has launched a new support package to help veterinary surgeons and nurses dealing with otitis externa, and to encourage compliance amongst owners whose dogs are being treated for the disease.
Called the Dermatology Partners in Practice programme, the initiative includes a client compliance pack which contains the Guide to Good Ear Care, a leaflet on handling techniques, a treatment diary and a consultation report.
Roger Brown, Senior Brand Manager at Dechra Veterinary Products, said: "We are committed to supporting vets and vet nurses as they deal with cases of otitis externa at a time when responsible use of antimicrobials is in the spotlight.
"It is essential that owners comply with treatment programmes and that vets are supported with involving owners, which can lead to better outcomes for dogs receiving treatment and can be good for developing the practice business as well.
"We know from our research, and from talking to the vets and vet nurses, that owner compliance can be a barrier to successful first-time management and resolution of otitis externa.
"The new Client Compliance Pack is designed to support veterinary professionals as they diagnose, control and maintain this complex condition."
"All in all, it will provide extra support to the owner as they carry through the professional treatment plan once back home."
Veterinary surgeons are being invited to arrange a Business Support Discussion to find out more about the Dermatology Partners in Practice Programme and how it can benefit their practice. For details and to know more about the pack, call 01939 211215 or visit dechra.co.uk/timetochange.
Talking to The Guardian, Hamaseh said: "This has really shocked me. We just discovered at the airport when we went to check in. I want people to know that this is not just happening to refugees. I am a graduate and I have a PhD. It has happened to a person who is working and who pays tax."
Hamaseh, who thought she'd have to find thousands of pounds to pay for an alternative flight home via another country, was quickly saved by a crowdfunding appeal by Women for Independence, which raised over £6000 in a matter of hours. The charity says it is donating everything in excess of the £2600 needed to get Hamaseh home to the Scottish Refugee Council.
Professor Anton Muscatelli, Principal of the University of Glasgow, said: "When I became aware on Saturday evening that one of our postgraduate veterinary students, Dr Hamaseh Tayari, was being prevented from travelling back from a holiday in Costa Rica through the United States and on to Glasgow I was both concerned and appalled. Concerned for the safety and well being of a young woman who, through no fault of her own, was stranded in Central America. Appalled because the reason for her predicament was not because she had done something wrong. Not because she was a danger to the security of the United States. But simply because she holds an Iranian passport."
He added: "Having spoken with Hamaseh I have been hugely impressed at how she is coping with the nightmare situation in which she finds herself. But I have been impressed too by the huge outpouring of support that has been shown across Scotland and the UK, particularly on twitter and through direct emails that have come in to the University from people who are outraged and want to help. All of this, I know, has greatly touched and heartened Hamaseh. I think it also confirms what we all like to believe is true. In this country we value individuals for what they are and the worth they bring, not for the stamp on their passport, the colour of their skin or the religion they practise."
Photo courtesy University of Glasgow
The HT Vista device is used by vets and vet nurses to screen dermal and subcutaneous masses on dogs.
The company says that with a negative predictive value of 98% clinicians can confidently classify a mass as benign without the need of further invasive tests.
HT Vista also says that, according to a recent client survey, the main features which practices value are the nurse-led ability which is maximising nurse clinics and streamlining efficiency, justification in sampling masses even when they feel innocuous, and the rapid speed of image acquisition and results.
To be in with a chance of winning the device and subscription, delegates must attend the 15-minute Ultra Demo at stand B300 on Friday 22nd March at 4pm.
Pfizer Animal Health is reminding horse owners of the importance of treating encysted small redworm larvae this autumn.
According to the company, these hidden, dormant parasites can account for up to 90% of the redworm burden in a horse (1). Furthermore, encysted small redworm larvae won't show up in a faecal egg count (FEC). Even if a horse has shown a negative or low count it could still be harbouring several million harmful larvae, hidden within the gut wall (2)
Encysted small redworm are a potential time bomb, with the ability to survive inside a horse for up to two years. They usually 'wake-up' in the late winter or early spring, developing and emerging from the gut wall all at the same time. Such a sudden mass emergence can cause a disease syndrome known as 'larval cyathostominosis', causing diarrhoea and colic with up to a 50% mortality rate (2). Treating encysted small redworm successfully in the late autumn or early winter is vitally important in order to prevent this serious risk.
Pfizer says that Moxidectin, the key ingredient of EQUEST, is recognised as the only single dose treatment for encysted small redworm. It has been shown to kill the larvae in-situ, without resulting in severe inflammation of the gut wall that other multi-dose treatments may cause (3). In addition, Moxidectin is licensed for persistent activity against small redworm over two weeks, killing larvae ingested as the horse grazes for up to two weeks after treatment.
Ben Gaskell, Pfizer's veterinary advisor said: "A responsible and sustainable worming programme involves good pasture management, regular diagnostic tests and targeted worming, carefully planned using specialist advice. However, it is also vital to remember the danger of encysted small redworm. Even if a horse's FEC is clear, there could still be a significant encysted small redworm burden that must be treated properly every year in late autumn / early winter."
1) Bairden K. et al (2001) Veterinary Record 148, 138-141 2) Dowdall S.M.J. et al (2002) Veterinary Parasitology 106, 225‑242 3) Steinbach T. et al (2006) Veterinary Parasitology 139, 115‑131
The British Association of Veterinary Emergency and Critical Care (BAVECC) is carrying out a survey of the veterinary profession about 24/7 emergency veterinary cover, the results of which will be presented to the RCVS Standards Committee during its forthcoming review.
Toby Birch MRCVS from BAVECC said: "We are aware that there has been much debate on the subject however we feel that much of what has been aired is subjective opinion. While we appreciate that this is very valuable, BAVECC would like to try and place some objectivity on this matter."
If you're working in small animal practice in the UK, please take part in the survey here: https://www.surveymonkey.com/s/JYKNC5J.
The results will be shared with members of VetSurgeon.org and VetNurse.co.uk in due course.
The new hydrolysed diet contains hydrolysed proteins, AuraGuard, fibres and Zeolite.
Dechra says the new formula featured in both diets offers superior palatability and works in a multi-action way with support of the gut-kidney axis to help optimise protein absorption and maintenance of muscle mass, gut barrier integrity and a healthy microbiome, while lowering uremic toxins in the blood.
The company says both diets control levels of protein, phosphorus and sodium and offer high levels of the Omega-3 fatty acids EPA and DHA.
Becky Morris, marketing manager at Dechra, said: "Chronic kidney disease is a lifelong progressive disease in dogs and cats, and nutrition is an important part of management to help slow disease progression, improve quality of life and reduce the risk of secondary complications.
"Our new and updated highly palatable Specific Heart & Kidney Support diets will help keep dogs and cats in good condition, prolonging the progression of the disease and the lifespan of the pet."
https://www.specific-diets.co.uk
With the end of the vector-free period and the threat of more cases of bluetongue, organisations from across all elements of the livestock sector have come together to launch a Joint campaign Against Bluetongue (JAB), with the strapline ‘don’t hesitate, vaccinate’.
The organisations involved, which represent livestock farmers, livestock markets and meat and dairy processing as well as the veterinary profession, all fully support the joint industry/Defra vaccination plan for bluetongue and are committed to working together on the campaign to achieve the mass vaccination of bluetongue susceptible animals, including goats and camelids.
JAB is now embarking on a major campaign to urge all farmers with susceptible livestock to vaccinate their animals as soon as vaccine is available and the BVA, along with our relevant specialist divisions, is committed to ensuring that vets have all the information in advance so that they are in a position to deal with their clients’ questions.
According to BVA President Nick Blayney: "Colleagues should be aware and look out for meetings being organised around the country, courtesy of the VLA and others, and led by vets where they can learn the latest information. The BVA website also carries useful and up-to-date information and links (http://www.bva.co.uk/policy/bluetongue_jab.asp). Practices are seen as the cornerstone of vaccine delivery, proper usage and monitoring for efficacy and BVA would encourage them to offer their clients the ability to register an interest in vaccine supply in advance of its arrival. Such a forward order book will speed up the delivery of the vaccine once it is available."
MSD Animal Heath has launched a new dispensing pack to help veterinary practices develop retail sales for Cosequin DS, the joint supplement for pets.
The new dispensing pack, which doubles up as a display pack, contains 300 chews foil-wrapped for extra freshness in 30 packs of 10 strips, allowing Cosequin to stand in the waiting room or on reception.
The new pack, available now in wholesalers, replaces the previous 90, 120 and 180 DS chewable tablet pack sizes.
Researchers at the Royal Veterinary College are seeking the help of veterinary surgeons in the UK who are treating dogs infected with Streptococcus zooepidemicus, a potentially fatal bacterial pneumonia-type disease which they say has been on the increase over the past five years.
The researchers are also trying to raise awareness of the signs of infection amongst vets and dog owners.
Streptococcus zooepidemicus is an infection that manifests itself similarly to human Toxic Shock Syndrome, causing a severe, bloody pneumonia in dogs. It has an acute onset and in a small proportion of cases the disease has been known to kill dogs within 24 hours of contracting the infection.
Outbreaks are sporadic, but particularly occur in situations where dogs mix in groups, such as rehoming or boarding kennels and in hunting and racing greyhound communities.
Although it is rarer in family pets, researchers are still keen to highlight the signs to owners, particularly if they regularly visit kennels or attend events where large groups of animals gather.
In the early stages, signs are similar to those of kennel cough, which is seen in similar environments. However, in Streptococcus zooepidemicus outbreaks, dogs rapidly become very ill and show very severe signs, with a mortality rate of up to 50% reported. In contrast to this, in more typical cases of kennel cough, most dogs will have a relatively mild illness and deaths are rare.
Researcher and veterinary pathologist Dr Simon Priestnall from the Royal Veterinary College said: "Although Streptococcus zooepidemicus was first identified in dogs in the 1970s, veterinarians and researchers have seen the number of cases spiral upwards over the past five years, particularly within rehoming kennels and the greyhound community. This suggests that the bacterium may have mutated to become more virulent and contagious.
"There is currently very limited public awareness of the problem. Signs for owners to look out for in their pets include a fever, which is usually accompanied by sneezing and nasal discharge which is often bloody, and their animal becoming lethargic. If owners notice the rapid onset of these signs, they are advised to seek veterinary help immediately. With prompt identification, medical treatment and supportive care, dogs can make a full recovery."
Dr Priestnall and his colleagues are working alongside the Animal Health Trust (Dr Andrew Waller) and the University of Nottingham School of Veterinary Medicine and Science (Drs Jenny Stavisky and Janet Daly) to investigate this potentially fatal bacterial pathogen.
They are developing a test that will allow them to determine, from a nasal or throat swab, how many dogs are suffering from the disease and how many are carriers. The hope is that by detecting patterns within the bacterial isolates or the infected dogs, they can uncover potential risk factors and limit the spread of the disease.
If you would like more information or to submit swab samples to help with the research into this disease, contact: spriestnall@rvc.ac.uk.
Elanco Animal Health, maker of Comfortis, Trifexis and Atopica, has launched ScratchTracker, a smartphone app designed to help dog owners with a simple way to monitor pruritus in their pet and share the results with their vet.
Elanco says ScratchTracker uses a scoring scale that has been developed by veterinary dermatologists and is proven to be an accurate and consistent way for pet owners to assess pruritus in dogs.
It's hoped the app will help veterinary surgeons track how a dog is responding to treatment and identify reasons for an increase in the dog's level of itchiness.
After downloading ScratchTracker from the Apple App Store or Google Play, pet owners are asked to rate how itchy their pet is by agreeing to a statement such as 'Extremely severe itching/almost continuous: itching doesn't stop whatever is happening, even in the consulting room' or 'Moderate itching/regular episodes: itching might occur at night, but not when eating, playing or exercising'. The reading will then be submitted and ScratchTracker will convert it to a numerical score tracking history which can be emailed from the app to the veterinary surgeon.
Alice Laurens, DVM MRCVS, product manager at Elanco Animal Health, said: "The ScratchTracker App is a useful tool to track pruritus in dogs for either a short period of time or for dogs suffering from a lifelong condition such as atopic dermatitis as part of a long term management programme."
For further information, contact your Elanco Animal Health key account manager or email: elancoCAH.uk@elanco.com
Boehringer Ingelheim has announced the results of an independent three-year study which demonstrates that dogs suffering from the most common type of heart failure lived longer (average time in the study of 267 days vs. 140 days) when treated with the product Vetmedin (pimobendan) compared with the ACE inhibitor benazepril hydrochloride.
According to Boehringer, results from the QUEST (Quality of Life and Extension of Survival Time) study, published in the September/October 2008 issue of the Journal of Veterinary Internal Medicine, mark a significant milestone in canine cardiac health.
25% of all small to medium-sized dogs over the age of seven are likely to suffer from heart disease at some point in their life, and 75% of those cases are caused by myxomatous mitral valve disease (MMVD), sometimes known as "valvular insufficiency" or "endocardiosis".
Adrian Boswood from the Royal Veterinary College, London, a Veterinary Cardiology Specialist and a lead-investigator on the study, said: "With QUEST demonstrating that dogs treated with Vetmedin live on average nearly twice as long as those on benazepril, it is now time for us as veterinary cardiologists and practising veterinarians to look again at how we are treating our patients suffering from this serious condition."
Dr. Michael O'Grady from the Ontario Veterinary College, University of Guelph, a fellow lead-investigator added, "The QUEST study provides compelling evidence that dogs with the most common form of heart failure should be receiving Vetmedin® as an essential part of their treatment regimen."
QUEST is the largest international study ever conducted looking at treatment for congestive heart failure (CHF) caused by MMVD, with 260 dogs studied in 11 countries, across three continents, over a period of three years.
The study was conducted by a team of 32 independent veterinary cardiologists from Australia, Canada, France, Germany and the United Kingdom among other countries.
For more information on the QUEST study and on CHF caused by MMVD, see http://www.questtrial.com/
Elanco has launched the second issue of its dermatology e-newsletter 'Under The Skin', which focuses on fleas and the problem of flea infestations.
Guest edited by Dr Peri Lau-Gillard DerMedVet CertVD DipECVD MRCVS, European Specialist in Veterinary Dermatology, the newsletter reviews the flea life cycle and considers their role as parasite and vector.
Other topics covered include 'seasonal treatment or year round prevention', 'treatment failure - what to consider when the fleas are still alive', 'tips and tricks - flea combing and faecal examination for fleas' and information about spinosad, the active ingredient in Comfortis.
There is also a chance to watch the recent 'real world flea control' webinar presented by flea expert, Dr Mike Dryden, together with a film demonstrating the effect of treatment with a Comfortis tablet on adult fleas.
Issue three of Under The Skin will take a closer look at the flea's role in allergic skin disease and how to manage these sometimes complex and frustrating cases.
To register to receive Elanco's Under The Skin e-newsletter, visit www.thewebinarvet.com/elanco.
As part of the campaign, vets are invited to share their top tips for maintaining a calm workplace for staff and patients at: https://www.nvsweb.co.uk/products/big-chill.
Veterinary professionals are being asked to share their top tips in two areas. Firstly, on how they prioritise self-care for themselves and teammates, and secondly, on how they best deal with nervous, stressed or anxious patients.
All respondents will be entered into a prize draw for a VetYogi practice subscription.
Gemma Vardy, Senior Category Specialist at NVS Group, said: “Mental health and wellbeing have never been more important within the veterinary industry which is why our dedicated Big Chill campaign supports the wellbeing and mental health of veterinary professionals while also shining a light on animal calming products, such as our select healthcare calming chews, which help support calm and enhance patient experiences.”
https://www.nvsweb.co.uk/products/big-chill
Schering-Plough has launched a new business development support package to help farm animal vets increase the proportion of beef and dairy producers vaccinating their cattle against bovine leptospirosis.
According to results from the Bovine Leptospirosis Information and Screening Service (BLiSS), leptospirosis is all but endemic in UK beef and dairy herds. Latest data continue to show that more than 70% of unvaccinated herds have been exposed to infection, yet only around one herd in three experiences the positive benefits and return on investment from vaccination.
Integral to the new Leptavoid-H business development package is updated information on the true cost of infertility in UK cattle herds. “Vets have been telling us they need up-to-date financial information to highlight the sub-fertility leptospirosis can cause. Now we’ve researched and produced the new costing data they need,” explained Paul Williams MRCVS, livestock veterinary adviser, Schering-Plough UK.
The new package helps practitioners identify vaccination growth opportunities by segmenting their client base and is also strong on marketing guidance. For each identified segment there are a series of practical actions - many supported by Schering-Plough materials and human resources - as well as hints, tips and sales tools to help vets convert opportunities into new business.
The supermarket Morrisons is to launch new pet food packaging which will alert shoppers to the ideal portion size their cat or dog should be eating, in a bid to tackle the UK's growing pet obesity problem.
Morrisons is the first supermarket to add portion control guidance to the front of their pet food packaging, and it follows research from Petplan which found that 36% of all dogs and 29% of cats treated by vets are obese. In addition, 71% of vets agree that cases of obesity are continuing to rise.
Each packet of Morrisons pet food will provide the correct portion for a healthy weight pet and, according to the company, the packaging will communicate the amount of servings each product provides clearly.
Apparently, 70% of owners believe that their dog or cat has never been overweight, which shows that there is a level of confusion amongst owners as to how much their pet is eating. A further 83% do not even worry about giving their pet too much food. Morrisons is aiming to make it easier for pet lovers to ensure their animal doesn't put on any unnecessary weight especially with Christmas just around the corner and the temptation of being fed leftovers and treats.
According to vets asked by Petplan there are five main reasons for an obesity problem amongst household pets. They are:
John Cannan, New Product Development Manager for Pet Food at Morrisons said: "We've had feedback from our customers which says that they are often in the dark about how much food they should be buying and giving their pet. Our new packaging will ensure that shoppers have a clearer sense of portion sizes whilst also saving them some pennies"
Brian Faulkner Petplan Vet of the Year said: "It's great to see Morrisons taking the lead on this and helping shoppers make more informed decisions about what they are feeding their pet. Whilst it's normal to give your animal a treat every now and then, pets do need to follow healthy regimes just like we do. Keeping your pet fit and healthy will ultimately save you money on veterinary bills as well."
Researchers from Highcroft Veterinary Referrals, the Royal Veterinary College and the University of Zurich are asking veterinary surgeons to take part in a survey designed to identify the rate of complications associated with Angiostrongylus vasorum (lungworm) infection or treatment in dogs.
The research, which is led by Drs Kieran Borgeat, Jose Matos and David Connolly, is the first step of a larger project, which hopes to culminate in the development of a set of consensus guidelines for the diagnosis and treatment of lungworm in dogs.
The researchers say that the guidelines are needed because there is currently no consensus amongst veterinary practitioners as to how dogs infected with Angiostrongylus vasorum (lungworm) are best treated. In addition, whilst there are anecdotal reports of adverse reactions after treatment, none are currently published in the literature.
The survey takes less than 10 minutes to complete, and all participants who leave their email address will be entered into a prize draw for £100 worth of Amazon vouchers.
No pharmaceutical or food companies have been involved in the design or funding of the research, and approval has been granted by the RVC Ethics and Welfare Committee.
The survey will close on 1st May 2016, or when 1000 responses have been completed. All information entered into the questionnaire will be completely anonymous and contact information will be held in a confidential database and not shared with any third parties.
To take part, visit http://tinyurl.com/lungwormsurvey
The University of Bristol’s School of Veterinary Sciences has announced the launch of an online map-based tool which forecasts the risk of a Nematodirus outbreak in lambs.
The Nematodirus risk map, which will be updated daily, is designed to help UK sheep farmers assess the risk of outbreaks of the parasite in their lambs and take action before it is too late. It includes treatment and management advice.
The online risk forecast was developed by SCOPS (Sustainable Control of Parasites in Sheep) and researchers at the University of Bristol’s School of Veterinary Sciences to predict when Nematodirus eggs will hatch and when outbreaks are likely to happen.
Researchers say that predicting when outbreaks might happen is becoming increasingly difficult due to variation in spring temperatures from year to year. Farmers can no longer rely on a standard timetable of treatments to avoid disease. As the damage is done by the larvae, faecal egg counts are of little use in detecting and controlling Nematodirus in young lambs.
The forecast takes advantage of the temperature-driven synchronised hatching of the Nematodirus larvae and uses weather data from 140 weather stations provided by the Met Office and Forecast.io. The interactive Google map allows farmers and advisers to select the nearest or most representative weather station and provides advice on how to relate the predicted risk to their particular farm and treatment options.
Cases of nematodirosis and eggs detected in routine faecal worm egg counts will also be mapped anonymously as they arise to improve the forecasts and SCOPS are asking farmers, advisors and diagnostic labs to contribute to these records by emailing researcher Dr Hannah Rose at the University of Bristol’s Vet School.
Dr Rose said: "In previous years 64 per cent of farmers and advisors surveyed changed the timing or extent of treatment – or advised treatment - after consulting the forecast, which has been running since 2013, and 93 per cent felt that their approach to control of this parasite had changed as a result of the forecast."
UK Government funding provided by the Biotechnology and Biological Sciences Research Council has enabled further development of the forecast and it is hoped that even more farmers will benefit in 2016.
Picture: A Romney sheep with its lambs, courtesy Dr Eric Morgan, University of Bristol
Bayer Animal Health is to hold a free webinar for companion animal veterinary surgeons about its new fluoroquinolone for cats and dogs, Veraflox.
The one-hour webinar begins with a talk on mutant prevention concentration (MPC) from Dr Joe Blondeau, head of clinical microbiology at the Royal University Hospital & the Saskatoon Health Region, in Canada. He's followed by Dr E Bensignor, President of the European College of Veterinary Dermatology, who will present the findings of clinical studies. The final presentation by Dr Joy Olsen, global veterinary services manager for Bayer Animal Health, reviews the features and characteristics of Veraflox (pradofloxacin) and its use in cats and dogs.
The webinar can be watched live on Tuesday 25 October at 7:30pm, when you'll have the opportunity to put questions to the speakers. Alternatively, a recording of the event can be viewed at any point afterwards.
To register, visit http://nl.webcast3.animalhealth.be/nl/english-subscription#ht=944, to receive a login name and password.
For further information on Veraflox, contact your Bayer representative or call 01635 563000.